Juvenile chronic myelogenous leukemia

American Journal of Clinical Pathology

Volumn 105, Issue 2, 1996, Pages 238-248

  Hess, Jay L ^a   Zutter, Mary M ^a   Castleberry, Robert P ^b   Emanuel, Peter D ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham Heersink School of Medicine   (United States)

Author keywords

Childhood diseases; Cytogenetics; Leukemia; Myeloproliferative disorders

Indexed keywords

CASE REPORT; CELL CULTURE; CHILD; CHILDHOOD CANCER; CHROMOSOME MARKER; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; COLONY FORMING UNIT; FEVER; HEPATOSPLENOMEGALY; HUMAN; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MALE; MYELOPROLIFERATIVE DISORDER; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; RASH; REVIEW;

EID: 0030023649     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.2.238     Document Type: Review

References (74)

1. Smith KL, Johnson W. Classification of chronic myelocytic leukemia in children. Cancer 1974;34:670-679.
2. Randall DL, Reiquam CW, Githens JH, Robinson A. Familial myeloproliferative disease. Am J Dis Child 1965;110:479-500.
3. Holten CP, Johnson WW. Chronic myelocytic leukemia in infant siblings. J Pediatr 1968;72:377-383.
4. Takanashi R. A pathological study on the juvenile type of chronic myeloid leukemia. Acta Pathologica Japonica 1972;22:489-508.
5. Castro-Malaspina H, Schaison G, Passe S, et al. Subacute and chronic myelomonocytic leukemia in children (juvenile CML): Clinical and hematologic observations, and identification of prognostic factors. Cancer 1984;54:675-686.
6. Freedman MH, Estrov Z, Chan SL. Juvenile chronic myelogenous leukemia. Am J Pediatr Hematol Oncol 1988, 10:261-267.
7. Bader JL, Miller RW. Neurofibromatosis and childhood leukemia. J Pediatr 1978;92:925-929.
8. Mays JA, Neerhout RC, Bagby GC, Koler RD. Juvenile chronic granulocytic leukemia: Emphasis on cutaneous manifestations and underlying neurofibromatosis. Am J Dis Child 1980;134: 654-658.
9. Gadner H, Haas OA. Experience in pediatric myelodysplastic syndromes. Hematol Oncol Clin North Am 1992;6:655-672.
10. Sires UI, Mallory SG, Dehner LP, et al. Cutaneous presentation of juvenile chronic myelogenous leukemia: A diagnostic and therapeutic dilemma. Ped Dermatol(in press).
11. Shaw NJ, Eden OB. Juvenile chronic myelogenous leukemia and neurofibromatosis in infancy presenting as ocular hemorrhage. Ped Hematol Oncol 1989;6:23-26.
12. Case Records of the Massachusetts General Hospital. Case 37-1994. N Engl J Med 1994;331:1005-1012.
13. Niemeyer C, Arico M, Biondi A, et al. Chronic myelomonocytic leukemia in childhood. Leuk Res 1994;18:6 (Abstr).
14. Krilov LR, Jacobson M, Shende A. Acute febrile neutrophilic dermatosis (Sweet's syndrome) presenting as facial cellulitis in a child with juvenile chronic myelogenous leukemia. Ped Infect Dis 1987;6:77-79.
15. Estrov Z, Zimmerman B, Grunberger T, et al. Characterization of malignant peripheral blood cells of juvenile chronic myelogenous leukemia. Cancer Res 1986;46:6456-6461.
16. Heskel NS, White CR, Fryberger S, et al. Aleukemic leukemia cutis: Juvenile chronic granulocytic leukemia presenting with figurate cutaneous lesions. J Am Acad Dermatol 1983;9:423-427.
17. Beaven GH, Ellis MJ, White JC. Studies on human foetal haemoglobin II: Foetal hemoglobin levels in healthy children and adults and in certain haematological disorders. Br J Haematol 1960;6:201-222.
18. Weatherall DJ, Clegg JB, Wood WG, et al. Foetal erythropoiesis in human leukemia. Nature (London) 1975;257:710-712.
19. Shimizu K, Keino H, Terasawa T, et al. Elevated haemoglobin F in juvenile and adult chronic myelogenous leukaemia. Acta Haemat 1988;80:28-33.
20. Weinberg RS, Leibowitz D, Weinblatt ME, et al. Juvenile chronic myelogenous leukaemia: The only example of truly fetal (not fetal-like) erythropoiesis. Br J Haematol 1990;76:307-310.
21. Weiss K, Stass S, Williams D, et al. Childhood monosomy 7 syndrome: Clinical and in vitro studies. Leukemia 1987;1:97-104.
22. Luna-Fineman S, Shannon KM, Lange BJ. Childhood monosomy 7: Epidemiology, biology and mechanistic implications. Blood 1995;85:1985-1999.
23. Butcher M, Frenck R, Emperor J, et al. Molecular evidence that monosomy 7 syndrome is distinct from juvenile chronic myelogenous leukemia and other childhood myeloproliferative disorders. Genes Chromosom Cancer 1995;12:50-57.
24. Alter BP, Sabra CG, Efremov GD, Gravely ME, Huisman TH. Globin chain electrophoresis: A new approach to the determination of the G/A ratio in fetal haemoglobin and to studies of globin synthesis. Br J Hematol 1980;44:527-534.
25. Maurer HS, Vida LN, Honig GR. Similarities of the erythrocytes in juvenile chronic myelogenous leukemia to fetal erythrocytes. Blood 1972;39:778-784.
26. Weatherall DJ, Edwards JA, Donohue WTA. Hemoglobin and red cell enzyme changes in juvenile myeloid leukaemia. BMJ 1968;1:679-681.
27. Sheridan BL, Weatherall DJ, Clegg JB, et al. The pattern of foetal hemoglobin production in leukaemia. Br J Hematol 1976;32: 487-506.
28. Shannon K, Nunez G, Dow LW. Juvenile chronic myelogenous leukemia: Surface antigen phenotyping by monoclonal antibodies and cytogenetic studies. Pediatrics 1986;77:330-335.
29. Lau RC, Squire J, Brisson L, et al. Lymphoid blast crisis of B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML). Leukemia 1994;8: 903-908.
30. Reisman LE, Trujillo JM. Chronic granulocytic leukemia of childhood: Clinical and cytogenetic studies. J Pediatr 1963;62:710-723.
31. Brodeur GM, Dow LW, William DL. Cytogenetic features of juvenile chronic myelogenous leukemia. Blood 1979;53:812-819.
32. Puchkova GP, Prigogina LL, Fleischman EW, et al. Chromosome abnormalities in chronic myeloid leukemia in children. Hum Genet 1983;64:257-262.
33. Inoue S, Ravindranath Y, Thompson RI. Cytogenetics of juvenile type chronic granulocytic leukemia. Cancer 1977;39:2017-2024.
34. Estrov Z, Grunberger T, Chan HSL, et al. Juvenile chronic myelogenous leukemia; characterization of the disease using cell cultures. Blood 1986;67:1382-1387.
35. Herrod HG, Dow LW, Sullivan JL. Persistent Epstein-Barr virus infection mimicking juvenile chronic myelogenous leukemia: Immunologic and hematologic studies. Blood 1983;61:1098-1104.
36. Brunning RD, McKenna RW. Tumors of the bone marrow. In: Rosai J, ed. Atlas of Tumor Pathology. Fasicle 9. Third Series. Washington, DC: Armed Forces Institute of Pathology, 1994, pp 448-450.
37. Kirby MA, Weitzman S, Freedman MH. Juvenile chronic myelogenous leukemia: Differentiation from infantile cytomegalovirus infection. Am J Pediatr Hematol/Oncol 1990;12:292-296.
38. Toren A, Neumann Y, Meyer JJ, et al. Malignant osteopetrosis manifested as juvenile chronic myeloid leukemia. Pediatr Hematol Oncol 1993;10:187-189.
39. Gerritsen EJA, Vossen JM, van Loo IH, et al. Autosomal recessive osteopetrosis: Variability of findings at diagnosis and during the natural course. Pediatrics 1994;93:247-253.
40. Altman AJ, Palmer CG, Baehner RL. Juvenile "chronic granulocytic leukemia": A panmyelopathy with prominent monocytic involvement and circulating monocyte colony-forming cells. Blood 1974;43:341-350.
41. Bagby GC, Dinarello CA, Neerhout RC, Ridgway D, McCall E. Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type. J Clin Invest 1988;82:1430-1436.
42. Gualtieri RJ, Castleberry RP, Gibbons J, et al. Cell culture studies and oncogene expression in juvenile chronic myelogenous leukemia. Exp Hematol 1988;16:613-619.
43. Gualtieri RJ, Emanuel PD, Zuckerman KS, et al. Granulocyte-macrophage colony stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia. Blood 1989;74:2360-2367.
44. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myelogenous leukemia hematopoietic progenitors. Blood 1991;77:925-929.
45. Koike K, Naganuma K, Ishii E, et al. Abnormal hemopoiesis in juvenile chronic myelogenous leukemia: Phagocytic cell-dependent endogenous colony formation by peripheral blood and bone marrow cells. Acta Hematologica Japonica 1985;48:750-755.
46. Emanuel PD, Bates LJ, Zhu S-W, Castleberry RP, Zuckerman KS. The role of monocyte-derived hematopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. Exp Hematol 1991;19:1017-1024.
47. Emanuel PD, Sokol JM. Interleukin-1 does not play a central role in juvenile chronic myelogenous leukemia [Letter]. Blood 1994;84:3236-3246.
48. Busque L, Gilliland DG, Prchal JT, et al. Clonality in juvenile chronic myelogenous leukemia. Blood 1995;85:21-30.
49. Amenomori T, Tomonaga M, Yoshida Y, et al. Cytogenetic evidence for partially committed myeloid progenitor cell origin of chronic myeloid leukemia: Both granulocyte-macrophage precursors and erythroid precursors carry identical marker chromosome. Br J Hematol 1986;64:539-546.
50. Satoh T, Nakafuku M, Miyajima A, et al. Involvement of ras p21 protein in signal transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci USA 1991;88:3314-3318.
51. Zuckerman KS, Emanuel PD, Xiaotang H. Molecular pathophysiology of juvenile chronic myeloid leukemia. In: Abraham NG, Marks PA, Konwalinka G, Sachs L, Tavassoli M, eds. Molecular Biology of Hematopoiesis. vol 2. Andover, UK: Intercept, 1992, pp 533-545.
52. Ballester R, Marchuk D, Boguski M, et al. The NF-1 locus encodes a protein functionally related to mammalion GAP and yeast IRA proteins. Cell 1990;63:851-859.
53. Buchberg AM, Cleveland LS, Jenkins NA. Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. Nature 1990;347:291-294.
54. Xu GF, O'Connell P, Viskochil D, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62: 599-608.
55. Martin GA, Viskochil D, Bollag G, et al. The GAP-related domain of the neurofibromatosis type I gene product interacts with ras p21. Cell 1990;63:843-849.
56. Xu GF, Lin B, Tanaka K, et al. The catalytic domain of the neurofibromatosis type I gene product stimulates ras GTPase and complements ras mutants of S. cervisiae. Cell 1990;63:835-841.
57. Shannon KM, O'Connell PO, Martin GA, et al. Loss of the normal NF-1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 1994;330:597-601.
58. Brodeur GM. The NF-1 gene in myelopoiesis and childhood myelodysplastic syndromes (Editorial). N Engl J Med 1994;330: 637-639.
59. ras. Blood 1994;84:3435-3439.
60. Miyauchi J, Asada M, Sasaki M, et al. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 1994;83: 2248-2254.
61. Pendergast AM, Quillian LA, Cripe LD, et al. BCR-ABL induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993;75:175-185.
62. Golub TR, Barker GF, Lovett M, Gilliland GM. Fusion of PDGF receptor to a normal ets-like gene tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994;77:307-316.
63. Chan HSL, Estrov Z, Weitzman SS, Freedman MH. The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia. J Clin Oncol 1987;5:1960-1967.
64. Festa RS, Shende A, Lanzkowsky P. Juvenile chronic myelogenous leukemia: Experience with combination chemotherapy. Med Pediatr Oncol 1990;18:311-316.
65. Sanders JE, Buckner CD, Stewart P, Thomas ED. Successful treatment of juvenile chronic myelogenous leukemia with marrow transplantation. Pediatrics 1979;63:44-46.
66. Sanders JE, Buckner CD, Thomas ED, et al. Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 1988;71:1144-1146.
67. Smith FO, Sanders JE, Robertson KA, Gooley T, Sievers EL. Allogeneic marrow transplantation (BMT) for children with juvenile chronic myelogenous leukemia (JCML). Blood 1994;84: 201a(suppl1)(Abstr).
68. Castleberry RP, Emanuel PD, Zuckerman KS, et al. A pilot study of 13-cis retinoic acid in the treatment of juvenile chronic myelogenous leukemia. N Engl J Med 1994;331:1680-1684.
69. Hasle H. Myelodysplastic syndromes in childhood-classification, epidemiology, and treatment. Leuk Lymphoma 1994;13:11-26.
70. Solal-Celigny P, Desaint B, Herrera A, et al. Chronic myelomonocytic leukemia according to FAB classification: Analysis of 35 cases. Blood 1984;63:634-638.
71. Teffer A, Hoagland HC, Therneau TM, Pierre RV. Chronic myelomonocytic leukemia: Natural history and prognostic determinants. Mayo Clin Proc 1989;64:1246-1254.
72. Storniolo AM, Moloney WC, Rosenthal DS, Cox C, Bennett JM. Chronic myelomonocytic leukemia. Leukemia 1990;4:766-770.
73. Heim S, Mitelman F. Chromosomal abnormalities in the myelodysplastic syndromes. Clin Hematol 1986;15:1003-1021.
74. Miller DR. Hematologic malignancies: Leukemia and lymphoma. In: Miller DR, Baehner RL, eds. Blood Diseases of Infancy and Childhood. ed 7. St. Louis: Mosby, 1995, p 722.